Voluntary corporate emissions targets not enough to create real climate action
Imperial and CNRS strengthen UK-France science with new partnerships
New AI startup accelerator led by Imperial opens for applications
We continue to develop a range of chemistry-led approaches to interrogate novel targets/techniques for the treatment of disease
Find out more about biological chemistry
We are actively exploring ways in which chiral materials can be used to enable/improve function in technological applications
Find out more about materials science
Enabling synthetic chemistry underpins all the ongoing research in the group
Find out more about Chemical Synthesis
The interaction of light with molecules continues to be a key area of research for the group
Find out more about Photochemistry